Olmesartan Medoxomil

Product NDC
0093-7611
11-digit product format
000937611
Labeler code
0093
Product ID
0093-7611_387f9f5f-a7d0-46d6-803e-7682600df334
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Olmesartan Medoxomil
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Teva Pharmaceuticals USA, Inc.
Application
ANDA091079
Marketing category
ANDA
Marketing start
2017-04-24
Marketing end
2019-11-30
Substance
OLMESARTAN MEDOXOMIL
Active strength
20 mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c19ec24d-2c40-4b8d-7c20-500ffa3660a1Product name320260303
96816964-c075-ffa7-b7b8-d8570411a3b9Product name720250305
caadbc51-b731-1a7b-b91a-f7bb4a62554eProduct name920240306
4a27501f-a987-48a5-99b4-e983d4744d76Product name720181211

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0093-7611-56EA - Each0093-76110df8426f-7540-4bb6-8d78-f62b276fd60a12017-05-03
0093-7611-98EA - Each0093-76111c28185c-d64e-431c-8341-7b3b8a1e97c512017-05-03

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
349401olmesartan medoxomil 20 MG Oral TabletPSN5212e6e8-d3dd-4e92-8352-81b9a8c5cf473
349401olmesartan medoxomil 20 MG Oral TabletSCD5212e6e8-d3dd-4e92-8352-81b9a8c5cf473